Ovoca Bio plc (ISE: OVXA)
Ireland flag Ireland · Delayed Price · Currency is EUR
0.0055
-0.0090 (-62.07%)
Aug 6, 2024, 9:00 PM GMT

Ovoca Bio Statistics

Total Valuation

Ovoca Bio has a market cap or net worth of EUR 1.22 million. The enterprise value is -1.70 million.

Market Cap 1.22M
Enterprise Value -1.70M

Important Dates

The next estimated earnings date is Tuesday, December 24, 2024.

Earnings Date Dec 24, 2024
Ex-Dividend Date n/a

Share Statistics

Ovoca Bio has 81.56 million shares outstanding. The number of shares has increased by 6.92% in one year.

Current Share Class n/a
Shares Outstanding 81.56M
Shares Change (YoY) +6.92%
Shares Change (QoQ) n/a
Owned by Insiders (%) 36.18%
Owned by Institutions (%) n/a
Float 52.06M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
PB Ratio 0.62
P/TBV Ratio 0.55
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 0.48
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.59

Current Ratio 3.59
Quick Ratio 3.59
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage 266.00

Financial Efficiency

Return on equity (ROE) is -108.96% and return on invested capital (ROIC) is 4.56%.

Return on Equity (ROE) -108.96%
Return on Assets (ROA) 3.70%
Return on Capital (ROIC) 4.56%
Revenue Per Employee n/a
Profits Per Employee -714,600
Employee Count 5
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -45.00% in the last 52 weeks. The beta is 0.91, so Ovoca Bio's price volatility has been similar to the market average.

Beta (5Y) 0.91
52-Week Price Change -45.00%
50-Day Moving Average 0.02
200-Day Moving Average 0.01
Relative Strength Index (RSI) 21.99
Average Volume (20 Days) 475

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income 266,000
Pretax Income -3.98M
Net Income -3.57M
EBITDA 595,000
EBIT 266,000
Earnings Per Share (EPS) -0.04
Full Income Statement

Balance Sheet

Cash & Cash Equivalents 2.93M
Total Debt n/a
Net Cash 2.93M
Net Cash Per Share 0.04
Equity (Book Value) 2.24M
Book Value Per Share 0.02
Working Capital 2.24M
Full Balance Sheet

Cash Flow

Operating Cash Flow 404,000
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Ovoca Bio does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -6.92%
Shareholder Yield -6.92%
Earnings Yield -273.28%
FCF Yield n/a

Stock Splits

The last stock split was on January 18, 2010. It was a reverse split with a ratio of 0.2.

Last Split Date Jan 18, 2010
Split Type Reverse
Split Ratio 0.2

Scores

Altman Z-Score n/a
Piotroski F-Score 3